ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

ALLO Allogene Therapeutics Inc

2,91
0,055 (1,93%)
27 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Allogene Therapeutics Inc ALLO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,055 1,93% 2,91 01:00:03
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,87 2,75 2,93 2,89 2,855
mais cotações »

Notícias Recentes

Data Hora Fonte Título
26/04/202409:30GLOBEAllogene Therapeutics Awarded Grant from the California..
09/04/202409:30GLOBEAllogene Therapeutics Announces Q2 Investor Conference..
14/03/202417:05GLOBEAllogene Therapeutics Reports Fourth Quarter and Full Year..
12/03/202409:30GLOBEAllogene Therapeutics and Arbor Biotechnologies Announce..
05/03/202410:30GLOBEAllogene Therapeutics to Report Fourth Quarter and Full Year..
28/02/202410:30GLOBEAllogene Therapeutics Announces Participation in the 44th..
16/02/202410:30GLOBEAllogene Therapeutics to Restate Previously Filed Financial..
16/01/202418:05GLOBEAllogene Therapeutics Announces Participation in Upcoming..
04/01/202418:15GLOBEAllogene Therapeutics and Foresight Diagnostics Announce..
04/01/202418:05GLOBEAllogene Therapeutics Announces 2024 Platform Vision to..
03/01/202418:05GLOBEAllogene Therapeutics to Host Conference Call Previewing its..
09/12/202314:00GLOBEAllogene Therapeutics Presents Comprehensive Safety Data of..
01/12/202310:30GLOBEAllogene Therapeutics Announces Participation in December..
03/11/202313:00GLOBEAllogene Therapeutics Presents Preclinical Data on Next..
02/11/202317:02GLOBEAllogene Therapeutics Reports Third Quarter 2023 Financial..
02/11/202310:00GLOBEAllogene Therapeutics Announces Poster Presentations at the..
30/10/202309:30GLOBEAllogene Therapeutics Announces Participation in November..
26/10/202309:30GLOBEAllogene Therapeutics to Report Third Quarter 2023 Financial..
16/10/202309:30GLOBEAllogene Therapeutics Appoints Geoffrey Parker as Chief..
27/09/202310:09GLOBEAllogene Therapeutics Announces Three Poster Presentations..
05/09/202309:30GLOBEAllogene Therapeutics Announces Participation in September..
14/08/202309:30GLOBEAllogene Therapeutics Appoints Earl Douglas as General..
02/08/202317:02GLOBEAllogene Therapeutics Reports Second Quarter 2023 Financial..
26/07/202309:30GLOBEAllogene Therapeutics to Report Second Quarter 2023..
11/07/202307:06VWEthereum Blockchain Game Pikamoon Raises $3.6m, Final ICO..
10/07/202311:44VWMassive Gaming Celebrates Global Launch of House of..
10/07/202306:52VWWOW EARN Wallet Offers One-Stop Shop Features, Now Available..
10/07/202306:02VWSwaap v2 Launches: Revolutionizing DeFi Market Making with..
08/07/202311:03VWBritanniacoin’s Official Pre-release: introducing a unique..
06/07/202312:59VWTether Launches USDt On Kava
06/07/202305:03VWOKX to Launch Signal Trading Platform, Empowering Traders..
05/07/202315:19VWHawkish Fed The Most Likely Reason For A Correction
30/06/202307:34VWMemecoin MOOKY Raises $900,000 Ahead of Its Final Presale..
28/06/202303:32VWDWF Labs Doubles Down on Conflux with $28 Million Invested
27/06/202309:00VWDealHub.io Acquires Usage-based Billing Company Subzee
27/06/202303:03VWOKX Liquid Marketplace Launches ‘Nitro Spreads’ Enabling..
26/06/202310:04VWMetaBlaze Announces $4M Crypto Presale Sellout, Gaming..
19/06/202312:29VWThe Top Most-Shorted Stocks Globally
15/06/202310:30GLOBEAllogene Therapeutics Provides Additional ALLO-501/501A..
14/06/202309:00GLOBEAllogene Therapeutics Announces Departure of Chief Financial..
09/06/202319:25GLOBEAllogene Therapeutics Announces Oral Presentation of Phase 1..
03/06/202310:00GLOBEAllogene Therapeutics Presents Updated ALLO-501/501A Phase 1..
24/05/202309:30GLOBEAllogene Therapeutics Announces Participation in Three..
11/05/202312:50GLOBEAllogene Therapeutics Announces Encore Presentation of Phase..
03/05/202317:02GLOBEAllogene Therapeutics Reports First Quarter 2023 Financial..

Seu Histórico Recente

Delayed Upgrade Clock